UCB's Global Corporate Website

UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology now and into the future.

We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives, while creating value for society. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.

Homepage-UCBCares

Homepage-Community-Health-Fund

Homepage-clinical-studies

IAR 2021 banner annual report V2

UCB's actions during COVID-19

UCB Stories & Newsroom

Story

4 Aug 2022

DCTx team working hand-in-hand with Epihunter

Story

Picture of a financial graph

28 Jul 2022

UCB HY2022 Financial Results: Strong performance, resilience and delivery

Press release

5 Aug 2022

Transparency notification FMR LLC

Read More

Driven to create breakthrough medicines
that will make a real difference to people's lives

Neil, UCB

Twitter Feed

Instagram Feed

ucb_biopharma Jul 25, 2022

ucb_biopharma Jul 15, 2022

At UCB, we take our responsibility
to the planet very seriously.

Read more about our green strategy

UCB Ventures, our strategic corporate venture fund
established in 2017

learn more about UCB Ventures

Homepage-disease-areas-V2

Discover our disease areas section